APO Research
Talk to an analyst

APO RESEARCH · REPORT

KD Pharma (Marine Ingredients)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global KD Pharma (Marine Ingredients) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

13 August 2026199 pages

Choose your research edition.

Industry ResearchKD Pharma (Marine Ingredients) Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal KD Pharma (Marine Ingredients) Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal KD Pharma (Marine Ingredients) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal KD Pharma (Marine Ingredients) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal KD Pharma (Marine Ingredients) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global KD Pharma (Marine Ingredients) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for KD Pharma (Marine Ingredients) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for KD Pharma (Marine Ingredients) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for KD Pharma (Marine Ingredients) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for KD Pharma (Marine Ingredients) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of KD Pharma (Marine Ingredients) include Cargill, Bio-marine Ingredients Ireland, Sopropeche, Hofseth BioCare ASA, TripleNine Group, SA Copalis, Symrise, Scanbio and Bio-Oregon Protein, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global KD Pharma (Marine Ingredients) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of KD Pharma (Marine Ingredients) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents KD Pharma (Marine Ingredients) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the KD Pharma (Marine Ingredients) market size, projected growth trends, production technologies, key applications, and end-use industries.

KD Pharma (Marine Ingredients) Segment by Company

Cargill

Bio-marine Ingredients Ireland

Sopropeche

Hofseth BioCare ASA

TripleNine Group

SA Copalis

Symrise

Scanbio

Bio-Oregon Protein

A. Costantino & C. S.P.A.

Alaska Protein Recovery

Gelita AG

Jiangxi Cosen Biochemical

Titan Biotech

KD Pharma (Marine Ingredients) Segment by Type

Protein

Ash

Fatty Acids

Others

KD Pharma (Marine Ingredients) Segment by Application

Poultry Feed

Aquaculture

Cosmetics & Personal Care

Other

KD Pharma (Marine Ingredients) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global KD Pharma (Marine Ingredients) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of KD Pharma (Marine Ingredients) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of KD Pharma (Marine Ingredients).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the KD Pharma (Marine Ingredients) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of KD Pharma (Marine Ingredients) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of KD Pharma (Marine Ingredients) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of KD Pharma (Marine Ingredients) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. KD Pharma (Marine Ingredients) Industry Trends Table 2. KD Pharma (Marine Ingredients) Industry Drivers Table 3. KD Pharma (Marine Ingredients) Industry Opportunities and Challenges Table 4. KD Pharma (Marine Ingredients) Industry Restraints Table 5. Global KD Pharma (Marine Ingredients) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global KD Pharma (Marine Ingredients) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global KD Pharma (Marine Ingredients) Sales by Manufacturers (k units) & (2021-2026) Table 8. Global KD Pharma (Marine Ingredients) Sales Market Share by Manufacturers Table 9. Global KD Pharma (Marine Ingredients) Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global KD Pharma (Marine Ingredients) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global KD Pharma (Marine Ingredients) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global KD Pharma (Marine Ingredients) Manufacturers, Product Type & Application Table 13. Global KD Pharma (Marine Ingredients) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global KD Pharma (Marine Ingredients) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Protein Table 17. Major Manufacturers of Ash Table 18. Major Manufacturers of Fatty Acids Table 19. Major Manufacturers of Others Table 20. Global KD Pharma (Marine Ingredients) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global KD Pharma (Marine Ingredients) Sales by Type (2021-2026) & (k units) Table 22. Global KD Pharma (Marine Ingredients) Sales by Type (2027-2032) & (k units) Table 23. Global KD Pharma (Marine Ingredients) Sales Market Share by Type (2021-2026) Table 24. Global KD Pharma (Marine Ingredients) Sales Market Share by Type (2027-2032) Table 25. Global KD Pharma (Marine Ingredients) Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global KD Pharma (Marine Ingredients) Revenue by Type (2021-2026) & (k units) Table 27. Global KD Pharma (Marine Ingredients) Revenue by Type (2027-2032) & (k units) Table 28. Global KD Pharma (Marine Ingredients) Revenue Market Share by Type (2021-2026) Table 29. Global KD Pharma (Marine Ingredients) Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Poultry Feed Table 31. Major Manufacturers of Aquaculture Table 32. Major Manufacturers of Cosmetics & Personal Care Table 33. Major Manufacturers of Other Table 34. Global KD Pharma (Marine Ingredients) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global KD Pharma (Marine Ingredients) Sales by Application (2021-2026) & (k units) Table 36. Global KD Pharma (Marine Ingredients) Sales by Application (2027-2032) & (k units) Table 37. Global KD Pharma (Marine Ingredients) Sales Market Share by Application (2021-2026) Table 38. Global KD Pharma (Marine Ingredients) Sales Market Share by Application (2027-2032) Table 39. Global KD Pharma (Marine Ingredients) Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global KD Pharma (Marine Ingredients) Revenue by Application (2021-2026) & (k units) Table 41. Global KD Pharma (Marine Ingredients) Revenue by Application (2027-2032) & (k units) Table 42. Global KD Pharma (Marine Ingredients) Revenue Market Share by Application (2021-2026) Table 43. Global KD Pharma (Marine Ingredients) Revenue Market Share by Application (2027-2032) Table 44. Global KD Pharma (Marine Ingredients) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global KD Pharma (Marine Ingredients) Sales by Region (2021-2026) & (k units) Table 46. Global KD Pharma (Marine Ingredients) Sales Market Share by Region (2021-2026) Table 47. Global KD Pharma (Marine Ingredients) Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global KD Pharma (Marine Ingredients) Sales Forecasted Market Share by Region (2027-2032) Table 49. North America KD Pharma (Marine Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America KD Pharma (Marine Ingredients) Sales by Country (2021-2026) & (k units) Table 51. North America KD Pharma (Marine Ingredients) Sales by Country (2027-2032) & (k units) Table 52. Europe KD Pharma (Marine Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe KD Pharma (Marine Ingredients) Sales by Country (2021-2026) & (k units) Table 54. Europe KD Pharma (Marine Ingredients) Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific KD Pharma (Marine Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific KD Pharma (Marine Ingredients) Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific KD Pharma (Marine Ingredients) Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa KD Pharma (Marine Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa KD Pharma (Marine Ingredients) Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa KD Pharma (Marine Ingredients) Sales by Country (2027-2032) & (k units) Table 61. Global KD Pharma (Marine Ingredients) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global KD Pharma (Marine Ingredients) Revenue by Region (2021-2026) & (US$ Million) Table 63. Global KD Pharma (Marine Ingredients) Revenue by Region (2027-2032) & (US$ Million) Table 64. Global KD Pharma (Marine Ingredients) Revenue Market Share by Region (2021-2026) Table 65. Global KD Pharma (Marine Ingredients) Revenue Market Share by Region (2027-2032) Table 66. Cargill Company Information Table 67. Cargill Business Overview Table 68. Cargill KD Pharma (Marine Ingredients) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Cargill KD Pharma (Marine Ingredients) Product Portfolio Table 70. Cargill Recent Development Table 71. Bio-marine Ingredients Ireland Company Information Table 72. Bio-marine Ingredients Ireland Business Overview Table 73. Bio-marine Ingredients Ireland KD Pharma (Marine Ingredients) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Bio-marine Ingredients Ireland KD Pharma (Marine Ingredients) Product Portfolio Table 75. Bio-marine Ingredients Ireland Recent Development Table 76. Sopropeche Company Information Table 77. Sopropeche Business Overview Table 78. Sopropeche KD Pharma (Marine Ingredients) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Sopropeche KD Pharma (Marine Ingredients) Product Portfolio Table 80. Sopropeche Recent Development Table 81. Hofseth BioCare ASA Company Information Table 82. Hofseth BioCare ASA Business Overview Table 83. Hofseth BioCare ASA KD Pharma (Marine Ingredients) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Hofseth BioCare ASA KD Pharma (Marine Ingredients) Product Portfolio Table 85. Hofseth BioCare ASA Recent Development Table 86. TripleNine Group Company Information Table 87. TripleNine Group Business Overview Table 88. TripleNine Group KD Pharma (Marine Ingredients) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. TripleNine Group KD Pharma (Marine Ingredients) Product Portfolio Table 90. TripleNine Group Recent Development Table 91. SA Copalis Company Information Table 92. SA Copalis Business Overview Table 93. SA Copalis KD Pharma (Marine Ingredients) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. SA Copalis KD Pharma (Marine Ingredients) Product Portfolio Table 95. SA Copalis Recent Development Table 96. Symrise Company Information Table 97. Symrise Business Overview Table 98. Symrise KD Pharma (Marine Ingredients) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Symrise KD Pharma (Marine Ingredients) Product Portfolio Table 100. Symrise Recent Development Table 101. Scanbio Company Information Table 102. Scanbio Business Overview Table 103. Scanbio KD Pharma (Marine Ingredients) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Scanbio KD Pharma (Marine Ingredients) Product Portfolio Table 105. Scanbio Recent Development Table 106. Bio-Oregon Protein Company Information Table 107. Bio-Oregon Protein Business Overview Table 108. Bio-Oregon Protein KD Pharma (Marine Ingredients) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Bio-Oregon Protein KD Pharma (Marine Ingredients) Product Portfolio Table 110. Bio-Oregon Protein Recent Development Table 111. A. Costantino & C. S.P.A. Company Information Table 112. A. Costantino & C. S.P.A. Business Overview Table 113. A. Costantino & C. S.P.A. KD Pharma (Marine Ingredients) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. A. Costantino & C. S.P.A. KD Pharma (Marine Ingredients) Product Portfolio Table 115. A. Costantino & C. S.P.A. Recent Development Table 116. Alaska Protein Recovery Company Information Table 117. Alaska Protein Recovery Business Overview Table 118. Alaska Protein Recovery KD Pharma (Marine Ingredients) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Alaska Protein Recovery KD Pharma (Marine Ingredients) Product Portfolio Table 120. Alaska Protein Recovery Recent Development Table 121. Gelita AG Company Information Table 122. Gelita AG Business Overview Table 123. Gelita AG KD Pharma (Marine Ingredients) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Gelita AG KD Pharma (Marine Ingredients) Product Portfolio Table 125. Gelita AG Recent Development Table 126. Jiangxi Cosen Biochemical Company Information Table 127. Jiangxi Cosen Biochemical Business Overview Table 128. Jiangxi Cosen Biochemical KD Pharma (Marine Ingredients) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Jiangxi Cosen Biochemical KD Pharma (Marine Ingredients) Product Portfolio Table 130. Jiangxi Cosen Biochemical Recent Development Table 131. Titan Biotech Company Information Table 132. Titan Biotech Business Overview Table 133. Titan Biotech KD Pharma (Marine Ingredients) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Titan Biotech KD Pharma (Marine Ingredients) Product Portfolio Table 135. Titan Biotech Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. KD Pharma (Marine Ingredients) Distributors List Table 139. KD Pharma (Marine Ingredients) Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. KD Pharma (Marine Ingredients) Product Image Figure 2. Global KD Pharma (Marine Ingredients) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global KD Pharma (Marine Ingredients) Market Size (2021-2032) & (US$ Million) Figure 4. Global KD Pharma (Marine Ingredients) Sales (2021-2032) & (k units) Figure 5. Global KD Pharma (Marine Ingredients) Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 KD Pharma (Marine Ingredients) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Protein Image Figure 9. Ash Image Figure 10. Fatty Acids Image Figure 11. Others Image Figure 12. Global KD Pharma (Marine Ingredients) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global KD Pharma (Marine Ingredients) Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global KD Pharma (Marine Ingredients) Sales Market Share by Type (2021-2032) Figure 15. Global KD Pharma (Marine Ingredients) Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global KD Pharma (Marine Ingredients) Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global KD Pharma (Marine Ingredients) Revenue Market Share by Type (2021-2032) Figure 18. Poultry Feed Image Figure 19. Aquaculture Image Figure 20. Cosmetics & Personal Care Image Figure 21. Other Image Figure 22. Global KD Pharma (Marine Ingredients) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global KD Pharma (Marine Ingredients) Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global KD Pharma (Marine Ingredients) Sales Market Share by Application (2021-2032) Figure 25. Global KD Pharma (Marine Ingredients) Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global KD Pharma (Marine Ingredients) Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global KD Pharma (Marine Ingredients) Revenue Market Share by Application (2021-2032) Figure 28. North America KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America KD Pharma (Marine Ingredients) Sales Market Share by Country (2021-2032) Figure 30. U.S. KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe KD Pharma (Marine Ingredients) Sales Market Share by Country (2021-2032) Figure 35. Germany KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 36. France KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific KD Pharma (Marine Ingredients) Sales Market Share by Country (2021-2032) Figure 42. China KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 46. India KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa KD Pharma (Marine Ingredients) Sales Market Share by Country (2021-2032) Figure 50. Brazil KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile KD Pharma (Marine Ingredients) Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global KD Pharma (Marine Ingredients) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global KD Pharma (Marine Ingredients) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America KD Pharma (Marine Ingredients) Revenue (2021-2032) & (US$ Million) Figure 61. North America KD Pharma (Marine Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe KD Pharma (Marine Ingredients) Revenue (2021-2032) & (US$ Million) Figure 63. Europe KD Pharma (Marine Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific KD Pharma (Marine Ingredients) Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific KD Pharma (Marine Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa KD Pharma (Marine Ingredients) Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa KD Pharma (Marine Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. KD Pharma (Marine Ingredients) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. KD Pharma (Marine Ingredients) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Protein
  • Ash
  • Fatty Acids
  • Others
Applications
  • Poultry Feed
  • Aquaculture
  • Cosmetics & Personal Care
  • Other
Companies covered
  • Cargill
  • Bio-marine Ingredients Ireland
  • Sopropeche
  • Hofseth BioCare ASA
  • TripleNine Group
  • SA Copalis
  • Symrise
  • Scanbio
  • Bio-Oregon Protein
  • A. Costantino & C. S.P.A.
  • Alaska Protein Recovery
  • Gelita AG
  • Jiangxi Cosen Biochemical
  • Titan Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global KD Pharma (Marine Ingredients) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global KD Pharma (Marine Ingredients) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global KD Pharma (Marine Ingredients) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global KD Pharma (Marine Ingredients) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global KD Pharma (Marine Ingredients) Market Dynamics
  1. 2.1 KD Pharma (Marine Ingredients) Industry Trends
  2. 2.2 KD Pharma (Marine Ingredients) Industry Drivers
  3. 2.3 KD Pharma (Marine Ingredients) Industry Opportunities and Challenges
  4. 2.4 KD Pharma (Marine Ingredients) Industry Restraints
3 KD Pharma (Marine Ingredients) Market by Manufacturers
  1. 3.1 Global KD Pharma (Marine Ingredients) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global KD Pharma (Marine Ingredients) Sales by Manufacturers (2021-2026)
  3. 3.3 Global KD Pharma (Marine Ingredients) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global KD Pharma (Marine Ingredients) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global KD Pharma (Marine Ingredients) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global KD Pharma (Marine Ingredients) Manufacturers, Product Type & Application
  7. 3.7 Global KD Pharma (Marine Ingredients) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global KD Pharma (Marine Ingredients) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 KD Pharma (Marine Ingredients) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 KD Pharma (Marine Ingredients) Tier 1, Tier 2, and Tier 3
4 KD Pharma (Marine Ingredients) Market by Type
  1. 4.1 KD Pharma (Marine Ingredients) Type Introduction
  2. 4.1.1 Protein
  3. 4.1.2 Ash
  4. 4.1.3 Fatty Acids
  5. 4.1.4 Others
  6. 4.2 Global KD Pharma (Marine Ingredients) Sales by Type
  7. 4.2.1 Global KD Pharma (Marine Ingredients) Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global KD Pharma (Marine Ingredients) Sales by Type (2021-2032)
  9. 4.2.3 Global KD Pharma (Marine Ingredients) Sales Market Share by Type (2021-2032)
  10. 4.3 Global KD Pharma (Marine Ingredients) Revenue by Type
  11. 4.3.1 Global KD Pharma (Marine Ingredients) Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global KD Pharma (Marine Ingredients) Revenue by Type (2021-2032)
  13. 4.3.3 Global KD Pharma (Marine Ingredients) Revenue Market Share by Type (2021-2032)
5 KD Pharma (Marine Ingredients) Market by Application
  1. 5.1 KD Pharma (Marine Ingredients) Application Introduction
  2. 5.1.1 Poultry Feed
  3. 5.1.2 Aquaculture
  4. 5.1.3 Cosmetics & Personal Care
  5. 5.1.4 Other
  6. 5.2 Global KD Pharma (Marine Ingredients) Sales by Application
  7. 5.2.1 Global KD Pharma (Marine Ingredients) Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global KD Pharma (Marine Ingredients) Sales by Application (2021-2032)
  9. 5.2.3 Global KD Pharma (Marine Ingredients) Sales Market Share by Application (2021-2032)
  10. 5.3 Global KD Pharma (Marine Ingredients) Revenue by Application
  11. 5.3.1 Global KD Pharma (Marine Ingredients) Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global KD Pharma (Marine Ingredients) Revenue by Application (2021-2032)
  13. 5.3.3 Global KD Pharma (Marine Ingredients) Revenue Market Share by Application (2021-2032)
6 Global KD Pharma (Marine Ingredients) Sales by Region
  1. 6.1 Global KD Pharma (Marine Ingredients) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global KD Pharma (Marine Ingredients) Sales by Region (2021-2032)
  3. 6.2.1 Global KD Pharma (Marine Ingredients) Sales by Region (2021-2026)
  4. 6.2.2 Global KD Pharma (Marine Ingredients) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America KD Pharma (Marine Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America KD Pharma (Marine Ingredients) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe KD Pharma (Marine Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe KD Pharma (Marine Ingredients) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific KD Pharma (Marine Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific KD Pharma (Marine Ingredients) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa KD Pharma (Marine Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa KD Pharma (Marine Ingredients) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global KD Pharma (Marine Ingredients) Revenue by Region
  1. 7.1 Global KD Pharma (Marine Ingredients) Revenue by Region
  2. 7.1.1 Global KD Pharma (Marine Ingredients) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global KD Pharma (Marine Ingredients) Revenue by Region (2021-2026)
  4. 7.1.3 Global KD Pharma (Marine Ingredients) Revenue by Region (2027-2032)
  5. 7.1.4 Global KD Pharma (Marine Ingredients) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America KD Pharma (Marine Ingredients) Revenue (2021-2032)
  8. 7.2.2 North America KD Pharma (Marine Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe KD Pharma (Marine Ingredients) Revenue (2021-2032)
  11. 7.3.2 Europe KD Pharma (Marine Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific KD Pharma (Marine Ingredients) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific KD Pharma (Marine Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa KD Pharma (Marine Ingredients) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa KD Pharma (Marine Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Cargill
  2. 8.1.1 Cargill Company Information
  3. 8.1.2 Cargill Business Overview
  4. 8.1.3 Cargill KD Pharma (Marine Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Cargill KD Pharma (Marine Ingredients) Product Portfolio
  6. 8.1.5 Cargill Recent Developments
  7. 8.2 Bio-marine Ingredients Ireland
  8. 8.2.1 Bio-marine Ingredients Ireland Company Information
  9. 8.2.2 Bio-marine Ingredients Ireland Business Overview
  10. 8.2.3 Bio-marine Ingredients Ireland KD Pharma (Marine Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bio-marine Ingredients Ireland KD Pharma (Marine Ingredients) Product Portfolio
  12. 8.2.5 Bio-marine Ingredients Ireland Recent Developments
  13. 8.3 Sopropeche
  14. 8.3.1 Sopropeche Company Information
  15. 8.3.2 Sopropeche Business Overview
  16. 8.3.3 Sopropeche KD Pharma (Marine Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sopropeche KD Pharma (Marine Ingredients) Product Portfolio
  18. 8.3.5 Sopropeche Recent Developments
  19. 8.4 Hofseth BioCare ASA
  20. 8.4.1 Hofseth BioCare ASA Company Information
  21. 8.4.2 Hofseth BioCare ASA Business Overview
  22. 8.4.3 Hofseth BioCare ASA KD Pharma (Marine Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hofseth BioCare ASA KD Pharma (Marine Ingredients) Product Portfolio
  24. 8.4.5 Hofseth BioCare ASA Recent Developments
  25. 8.5 TripleNine Group
  26. 8.5.1 TripleNine Group Company Information
  27. 8.5.2 TripleNine Group Business Overview
  28. 8.5.3 TripleNine Group KD Pharma (Marine Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 TripleNine Group KD Pharma (Marine Ingredients) Product Portfolio
  30. 8.5.5 TripleNine Group Recent Developments
  31. 8.6 SA Copalis
  32. 8.6.1 SA Copalis Company Information
  33. 8.6.2 SA Copalis Business Overview
  34. 8.6.3 SA Copalis KD Pharma (Marine Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SA Copalis KD Pharma (Marine Ingredients) Product Portfolio
  36. 8.6.5 SA Copalis Recent Developments
  37. 8.7 Symrise
  38. 8.7.1 Symrise Company Information
  39. 8.7.2 Symrise Business Overview
  40. 8.7.3 Symrise KD Pharma (Marine Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Symrise KD Pharma (Marine Ingredients) Product Portfolio
  42. 8.7.5 Symrise Recent Developments
  43. 8.8 Scanbio
  44. 8.8.1 Scanbio Company Information
  45. 8.8.2 Scanbio Business Overview
  46. 8.8.3 Scanbio KD Pharma (Marine Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Scanbio KD Pharma (Marine Ingredients) Product Portfolio
  48. 8.8.5 Scanbio Recent Developments
  49. 8.9 Bio-Oregon Protein
  50. 8.9.1 Bio-Oregon Protein Company Information
  51. 8.9.2 Bio-Oregon Protein Business Overview
  52. 8.9.3 Bio-Oregon Protein KD Pharma (Marine Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bio-Oregon Protein KD Pharma (Marine Ingredients) Product Portfolio
  54. 8.9.5 Bio-Oregon Protein Recent Developments
  55. 8.10 A. Costantino & C. S.P.A.
  56. 8.10.1 A. Costantino & C. S.P.A. Company Information
  57. 8.10.2 A. Costantino & C. S.P.A. Business Overview
  58. 8.10.3 A. Costantino & C. S.P.A. KD Pharma (Marine Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 A. Costantino & C. S.P.A. KD Pharma (Marine Ingredients) Product Portfolio
  60. 8.10.5 A. Costantino & C. S.P.A. Recent Developments
  61. 8.11 Alaska Protein Recovery
  62. 8.11.1 Alaska Protein Recovery Company Information
  63. 8.11.2 Alaska Protein Recovery Business Overview
  64. 8.11.3 Alaska Protein Recovery KD Pharma (Marine Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Alaska Protein Recovery KD Pharma (Marine Ingredients) Product Portfolio
  66. 8.11.5 Alaska Protein Recovery Recent Developments
  67. 8.12 Gelita AG
  68. 8.12.1 Gelita AG Company Information
  69. 8.12.2 Gelita AG Business Overview
  70. 8.12.3 Gelita AG KD Pharma (Marine Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Gelita AG KD Pharma (Marine Ingredients) Product Portfolio
  72. 8.12.5 Gelita AG Recent Developments
  73. 8.13 Jiangxi Cosen Biochemical
  74. 8.13.1 Jiangxi Cosen Biochemical Company Information
  75. 8.13.2 Jiangxi Cosen Biochemical Business Overview
  76. 8.13.3 Jiangxi Cosen Biochemical KD Pharma (Marine Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Jiangxi Cosen Biochemical KD Pharma (Marine Ingredients) Product Portfolio
  78. 8.13.5 Jiangxi Cosen Biochemical Recent Developments
  79. 8.14 Titan Biotech
  80. 8.14.1 Titan Biotech Company Information
  81. 8.14.2 Titan Biotech Business Overview
  82. 8.14.3 Titan Biotech KD Pharma (Marine Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Titan Biotech KD Pharma (Marine Ingredients) Product Portfolio
  84. 8.14.5 Titan Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 KD Pharma (Marine Ingredients) Value Chain Analysis
  2. 9.1.1 KD Pharma (Marine Ingredients) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 KD Pharma (Marine Ingredients) Production Mode & Process
  6. 9.2 KD Pharma (Marine Ingredients) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 KD Pharma (Marine Ingredients) Distributors
  9. 9.2.3 KD Pharma (Marine Ingredients) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst